Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma
We report a case in which BIA-ALCL and breast cancer were not detected preoperatively, with subsequent removal of a ruptured breast implant. A 52-year-old woman had silicone breast implants on both sides for breast augmentation 15 years ago. Right axillary lymphadenopathy and intracapsular ruptures were noted by magnetic resonance imaging. Right axillary lymph node biopsy was performed at our department of breast surgery. Flow cytometry for BIA-ALCL was also performed using the exudate around the implant. The results were negative for breast cancer and BIA-ALCL. However, taking into consideration exacerbation of breast imp...
Source: Nagoya Journal of Medical Science - December 29, 2023 Category: International Medicine & Public Health Authors: Hitomi Takahashi Hideyoshi Sato Yukiyo Tsunekawa Urara Fujioka Yumi Wanifuchi-Endo Tatsuya Toyama Kazuhiro Toriyama Source Type: research
Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma
CONCLUSION: Perlecan expression measured by immunohistochemical staining is associated with aggressive characteristics in breast cancer, suggesting that Perlecan may help in cancer progression and can be investigated as a possible target therapy.PMID:38156864 | DOI:10.31557/APJCP.2023.24.12.4277 (Source: Asian Pacific Journal of Cancer Prevention)
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2023 Category: Cancer & Oncology Authors: Samar Ibrahim Amer Ismail Engy Talaat Helmy Ahmed Mahmoud Abdel Aziz Passant Essam Eldin Shibel Source Type: research
Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma
We report a case in which BIA-ALCL and breast cancer were not detected preoperatively, with subsequent removal of a ruptured breast implant. A 52-year-old woman had silicone breast implants on both sides for breast augmentation 15 years ago. Right axillary lymphadenopathy and intracapsular ruptures were noted by magnetic resonance imaging. Right axillary lymph node biopsy was performed at our department of breast surgery. Flow cytometry for BIA-ALCL was also performed using the exudate around the implant. The results were negative for breast cancer and BIA-ALCL. However, taking into consideration exacerbation of breast imp...
Source: Nagoya Journal of Medical Science - December 29, 2023 Category: International Medicine & Public Health Authors: Hitomi Takahashi Hideyoshi Sato Yukiyo Tsunekawa Urara Fujioka Yumi Wanifuchi-Endo Tatsuya Toyama Kazuhiro Toriyama Source Type: research
Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma
CONCLUSION: Perlecan expression measured by immunohistochemical staining is associated with aggressive characteristics in breast cancer, suggesting that Perlecan may help in cancer progression and can be investigated as a possible target therapy.PMID:38156864 | DOI:10.31557/APJCP.2023.24.12.4277 (Source: Asian Pacific Journal of Cancer Prevention)
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2023 Category: Cancer & Oncology Authors: Samar Ibrahim Amer Ismail Engy Talaat Helmy Ahmed Mahmoud Abdel Aziz Passant Essam Eldin Shibel Source Type: research
Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma
We report a case in which BIA-ALCL and breast cancer were not detected preoperatively, with subsequent removal of a ruptured breast implant. A 52-year-old woman had silicone breast implants on both sides for breast augmentation 15 years ago. Right axillary lymphadenopathy and intracapsular ruptures were noted by magnetic resonance imaging. Right axillary lymph node biopsy was performed at our department of breast surgery. Flow cytometry for BIA-ALCL was also performed using the exudate around the implant. The results were negative for breast cancer and BIA-ALCL. However, taking into consideration exacerbation of breast imp...
Source: Nagoya Journal of Medical Science - December 29, 2023 Category: International Medicine & Public Health Authors: Hitomi Takahashi Hideyoshi Sato Yukiyo Tsunekawa Urara Fujioka Yumi Wanifuchi-Endo Tatsuya Toyama Kazuhiro Toriyama Source Type: research
Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma
CONCLUSION: Perlecan expression measured by immunohistochemical staining is associated with aggressive characteristics in breast cancer, suggesting that Perlecan may help in cancer progression and can be investigated as a possible target therapy.PMID:38156864 | DOI:10.31557/APJCP.2023.24.12.4277 (Source: Asian Pacific Journal of Cancer Prevention)
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2023 Category: Cancer & Oncology Authors: Samar Ibrahim Amer Ismail Engy Talaat Helmy Ahmed Mahmoud Abdel Aziz Passant Essam Eldin Shibel Source Type: research
Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma
We report a case in which BIA-ALCL and breast cancer were not detected preoperatively, with subsequent removal of a ruptured breast implant. A 52-year-old woman had silicone breast implants on both sides for breast augmentation 15 years ago. Right axillary lymphadenopathy and intracapsular ruptures were noted by magnetic resonance imaging. Right axillary lymph node biopsy was performed at our department of breast surgery. Flow cytometry for BIA-ALCL was also performed using the exudate around the implant. The results were negative for breast cancer and BIA-ALCL. However, taking into consideration exacerbation of breast imp...
Source: Nagoya Journal of Medical Science - December 29, 2023 Category: International Medicine & Public Health Authors: Hitomi Takahashi Hideyoshi Sato Yukiyo Tsunekawa Urara Fujioka Yumi Wanifuchi-Endo Tatsuya Toyama Kazuhiro Toriyama Source Type: research
Immunohistochemical Evaluation of Perlecan (Heparan Sulphate Proteoglycan 2) Expression in Invasive Female Breast Carcinoma
CONCLUSION: Perlecan expression measured by immunohistochemical staining is associated with aggressive characteristics in breast cancer, suggesting that Perlecan may help in cancer progression and can be investigated as a possible target therapy.PMID:38156864 | DOI:10.31557/APJCP.2023.24.12.4277 (Source: Asian Pacific Journal of Cancer Prevention)
Source: Asian Pacific Journal of Cancer Prevention - December 29, 2023 Category: Cancer & Oncology Authors: Samar Ibrahim Amer Ismail Engy Talaat Helmy Ahmed Mahmoud Abdel Aziz Passant Essam Eldin Shibel Source Type: research
Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma
We report a case in which BIA-ALCL and breast cancer were not detected preoperatively, with subsequent removal of a ruptured breast implant. A 52-year-old woman had silicone breast implants on both sides for breast augmentation 15 years ago. Right axillary lymphadenopathy and intracapsular ruptures were noted by magnetic resonance imaging. Right axillary lymph node biopsy was performed at our department of breast surgery. Flow cytometry for BIA-ALCL was also performed using the exudate around the implant. The results were negative for breast cancer and BIA-ALCL. However, taking into consideration exacerbation of breast imp...
Source: Nagoya Journal of Medical Science - December 29, 2023 Category: International Medicine & Public Health Authors: Hitomi Takahashi Hideyoshi Sato Yukiyo Tsunekawa Urara Fujioka Yumi Wanifuchi-Endo Tatsuya Toyama Kazuhiro Toriyama Source Type: research
